Epilepsy: Topiramate is indicated as monotherapy in patients with newly diagnosed epilepsy or for conversion to monotherapy in patients with epilepsy. Topiramate is indicated as adjunctive therapy for adults and children aged 2 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox Gastaut syndrome. Migraine: Topiramate is indicated in adults for the prophylaxis of migraine headache. Topiramate has not been studied in the treatment of acute migraine attacks or in other types headache.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

Topiramate is available in tablet formulation for oral administration. It is recommended that topiramate not be broken. Topiramate can be taken without regard to meals.